SA

Sivasantosh Andhavarapu

Active Director Director DIN 10822377
DIN 10822377 First appointment Oct 2024
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Sivasantosh Andhavarapu

Data last updated:

Sivasantosh Andhavarapu is a Director at Crasenim Pharma Private Limited (since 2024).

DIN 10822377
Primary Designation Director
First Appointment 28 Oct 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Crasenim Pharma Private Limited U46497AP2024PTC116468
Director28 Oct 20242024Active

Board colleagues of Sivasantosh Andhavarapu

NameDINCompanyDesignation
Chanati Karuna10822378Crasenim Pharma Private LimitedManaging Director

Directorship timeline

Open interactive timeline →
Crasenim Pharma Private Limited
Premium access

Shareholding and investment profile for Sivasantosh Andhavarapu

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sivasantosh Andhavarapu

Sivasantosh Andhavarapu currently holds 1 directorship: Crasenim Pharma Private Limited (Director, since 28 Oct 2024).

Sivasantosh Andhavarapu was first appointed on 28 Oct 2024 as Director at Crasenim Pharma Private Limited.

The current boards of Sivasantosh Andhavarapu's companies include Chanati Karuna (Crasenim Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available